CClinicalTrials.gg
CompletedNCT01531504Updated Dec 28, 2012

New Use of the ViKY Device for Uterus Positioning

An interventional study of ViKY UP in Surgical Procedure, Unspecified, sponsored by EndoControl. Completed at 2 sites in United States. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2012-12-28.

Sponsored by EndoControl · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
Female
01

Study summary

Evaluation of Safety and Efficacy of ViKY Device for Uterus Positioning on 2 US sites

Read the detailed description

The ViKY device "Vision Control for endoscopy" was initially a compact motorized endoscope holder for laparoscopic surgery. It holds the endoscope and is controlled by either a foot pedal or voice activation. It received FDA approval in December 2008 and since that time has been used to facilitate laparoscopic surgery in multiple specialties.

EndoControl now considers using the technology for uterus manipulation in laparoscopic-assisted hysterectomies. Most gynecologic surgeries require displacement of the uterus out of the anatomic location to optimize the surgery. During an abdominal hysterectomy clamps are placed on the uterine cornua allowing easy manipulation of the uterus. The development of laparoscopic surgery required new techniques to manipulate the uterus. Typically a uterine manipulator is placed vaginally and controlled by the surgeon or the surgical assistant during the procedure.

In conventional operations, the constant physical force decreases the surgical team's efficacy and increases fatigue levels. The use of the ViKY device to control the position of the uterus facilitates surgery by enabling the surgeon to maintain a constant "locked" position or by allowing the surgeon to remotely move the uterus at any point of the surgery. The ViKY device also eliminates the need for an extra surgical assistant during laparoscopic-assisted hysterectomies.

The aim of this study is to collect data to demonstrate safety and effectiveness of the use of the ViKY device for uterine manipulation during conventional laparoscopic-assisted hysterectomies or computer-controlled laparoscopic hysterectomies.

02

Conditions studied

  • Surgical Procedure, Unspecified

Keywords

  • hysterectomies
  • uterine manipulator
03

In context

Lead sponsor

This is the only study on the registry with EndoControl as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-80
  • Candidate for conventional laparoscopic-assisted hysterectomies procedures
  • patient has a cervix and a uterus

Exclusion criteria

Exclusion criteria

  • Difficulty understanding the English language
  • Anatomy that precludes the use of a uterine manipulator
  • Current inclusion in another research study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Other
    Hysterectomy

    candidate for a conventional laparoscopic-assisted

    Device: ViKY UP

Interventions

  • DeviceViKY UP

    laparoscopic-assisted hysterectomy procedure

06

What researchers measure

Primary outcomes

  1. Effectiveness

    Number of cases with adequate visualization of pelvic anatomy during endoscopy.

    Time frame: 4 months

  2. Adverse Events

    Number of perforations during intervention. Number of complications associated with the use of uterine manipulator

    Time frame: 4 months

Secondary outcomes

  1. surgery characterization

    Duration of time of each procedure, duration of time to set up Viky UP device

    Time frame: 4 months

07

Study locations

2 sites
  • Florida Hospital
    Orlando, Florida 32804, United States
  • Carolinas Medical Center
    Charlotte, North Carolina 28203, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 28, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01531504
Lead sponsor
EndoControl
Responsible party
Sponsor
First posted
Feb 13, 2012
Start date
Dec 2011
Primary completion
Aug 2012
Completion
Sep 2012
Last update
Dec 28, 2012

Study contacts

Arnold ADVINCULA, MD
principal investigator · Floridal Hospital
Kevin STEPP, MD
principal investigator · Carolinas Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion